EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

Judi Clinical Journal

ISSN 3105-4102 · Smart Health Tower

Latest articles

  1. Dyshormonogenetic Goiter: A Case Series

    Abdulwahid M. Salih, Ari M. Abdullah, Aso N. Qadir, Abdullah A. Qadir, Shko H. Hassan, Shalaw A. Nasraldeen, Saeed H. Ali, Muhammad H. Ali, Mohammed L. Ahmed, Osama A. Ali, Abdullah O. Hassan, Mohammed H. Rifaat, Daroo A. Kareem, Hawzhan Abubakr Abdalla, Sarkrda Mohammed Jamal

    Published: 2026-09-15DOI: 10.70955/jcj.2026.10

  2. Current Perspectives on Cystic Echinococcosis: A Systematic Review

    Hawkar A. Nasralla, Berun A. Abdalla, Hiwa O. Abdullah, Sasan M. Ahmed, Fahmi H. Kakamad, Shvan H. Mohammed, Rawezh Q. Salih, Dahat A. Hussein, Tomas M. Mikael, Marwan N. Hassan, Hunar A. Hassan, Suhaib H. Kakamad, Kayhan A. Najar, Karukh K. Mohammed, Diyar A. Omar, Shadi H. Sidiq, Fakher Abdullah, Yousif M. Mahmood

    Published: 2025-02-02DOI: 10.70955/jcj.2025.1

  3. Male Breast Cancer: A Single Center Case Series

    Abdulwahid M. Salih, Lana RA. Pshtiwan, Fattah H. Fattah, Ari M. Abdullah, Rebaz M. Ali, Rebaz O. Mohammed, Hiwa O. Baba, Ahmed H. Ahmed, Sakar O. Arif, Nasren S. Sabr, Shko H. Hassan, Harzal H. Fatih, Masty K. Ahmed, Meer M. Abdulkarim, Hiwa O. Abdullah, Fahmi H. Kakamad

    Published: 2025DOI: 10.70955/jcj.2025.11

  4. Pembrolizumab and Sarcoma: A meta-analysis

    Rebaz M. Ali, Sami S. Omar, Shalaw H. Abdalla, Fattah H. Fattah, Shnya R. Hamalaw, Hussein M. Hamasalih, Ayman M. Mustafa, Sanaa O. Karim, Yousif M. Mahmood, Meer M. Abdulkarim, Ahmed G. Hamasaeed, Dana O. Karim, Abdullah D. Ahmad

    Published: 2025DOI: 10.70955/jcj.2025.6

Volumes

2026 · 102025 · 16

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.